Highest-materiality recent filing
Corteva Delivers Strong Q1 2026: EPS $1.07 GAAP, $1.50 Operating; Reaffirms FY Outlook
Net sales $4.905B (+11% YoY); organic sales +7%. GAAP net income $725M ($1.07 EPS).
Corteva stockholders elect all 12 director nominees and approve say-on-pay at 2026 annual meeting
All 12 director nominees elected with strong majority support; broker non-votes 51.6M.
Corteva names Luke Kissam CEO of New Corteva; reveals SpinCo leadership for planned separation
Luke Kissam, former Albemarle CEO, to lead New Corteva (crop protection) at Q4 2026 spin-off; joins June 1 as crop protection BU CEO.
Corteva FY2025 sales $17.4B (+3%), EBITDA $3.85B; guides 2026 EBITDA $4.0-4.2B; settles Bayer
Full-year GAAP EPS from cont ops $1.75, up 43% YoY; Operating EPS $3.34, up 30%.
Corteva raises FY2025 guidance; Q3 op EBITDA $49M; plans spin-off in H2 2026
Q3 net sales $2.62B, +13% YoY; GAAP loss $308M (loss $0.46) vs loss $519M prior year.
Corteva to split into two public companies via tax-free spin-off by H2 2026
Board unanimously approved plan to separate into two independent public companies via tax-free spin-off expected in H2 2026.
Corteva appoints Jennifer Johnson Chief Legal Officer; Cornel Fuerer to retire in 2026
Jennifer Johnson becomes SVP, Chief Legal Officer effective Sept 15, 2025, succeeding Cornel Fuerer.
Corteva Q2 GAAP EPS $2.02, op EPS $2.20; raises FY2025 guidance
Q2 GAAP EPS $2.02 (up 34% YoY); operating EPS $2.20 (up 20%).
Corteva Q1 2025: EPS $0.97 GAAP, $1.13 operating; reaffirms FY guidance
GAAP EPS $0.97 from cont. ops (+83% YoY); operating EPS $1.13 (+27% YoY).
Corteva stockholders elect all 12 director nominees, approve say-on-pay, ratify PwC
All 12 director nominees elected; average ~98.2% votes for across candidates (excluding broker non-votes).
Corteva director Rebecca Liebert resigns, effective Feb 28, 2025
Rebecca Liebert, Ph.D. informed board on Feb 13, 2025 of resignation to pursue other opportunities.
GAAP diluted EPS from continuing ops -$0.08 in Q4 vs -$0.33 a year ago; Operating EPS $0.32, up 113% YoY.
Corteva reports Q3 loss, updates FY guidance, announces restructuring cost increase
Q3 2024 net sales $2.33B (-10% YoY); GAAP loss from cont. ops $519M; GAAP EPS -$0.76.
Corteva names Judd O'Connor EVP Seed Business Unit as Tim Glenn retires Dec 1, 2024
Tim Glenn will retire effective December 1, 2024, and serve as strategic advisor through Q1 2025.
Corteva Q2 GAAP EPS $1.51, up 23% YoY; cuts FY guidance; names new CFO
Seed EBITDA +16% to $1.70B on 5% price lift; Crop Protection EBITDA -20% to $255M on pricing pressure.
Corteva stockholders approve officer exculpation amendment at annual meeting
All 13 director nominees elected with >94% support from votes cast, excluding broker non-votes.
Corteva Q1 net sales down 8% to $4.49B, EPS $0.53; reaffirms FY guidance
GAAP EPS from continuing ops $0.53 vs $0.84 prior year; operating EPS (non-GAAP) $0.89 vs $1.16.
Q4 net sales $3.71B (-3% YoY); GAAP loss from cont. ops $231M (EPS -$0.33).
Rebecca Liebert, Ph.D. informed the Corteva, Inc. (the “Company”) Board of Directors (the “Board”) on February 13, 2025 that she intends to pursue other opportunities and, therefore, will resign from her position as a director on the Company’s Board effective February 28, 2025.
Judd O’Connor, age 54, will replace Mr. Glenn effective December 1, 2024.
Timothy Glenn, executive vice president, seed business unit, notified the Company on October 10, 2024 of his intent to retire effective December 1, 2024.
David P. Johnson, age 57, will replace Mr. Anderson as executive vice president and chief financial officer effective September 16, 2024.
David J. Anderson, executive vice president and chief financial officer, notified the Company on July 26, 2024, of his intent to retire effective September 16, 2024.
Max materiality 0.90 · Median 0.72 · Most common event earnings